NHS to trial innovative cancer blood test
The NHS is trialling an innovative new blood test that [...]
Managing adverse events in kidney cancer patients on immunotherapy/TKI combination treatment
In this video interview, Dr Eric Jonasch from MD Anderson [...]
Cabozantinib plus atezolizumab for non-clear cell kidney cancer
In this video interview, Dr Monty Pal from the City [...]
Managing immune-related adverse events
In these video interviews, Dr Eric Jonasch from MD Anderson [...]
Probiotic supplements and improves clinical benefit in kidney cancer
This prospective, randomised study in 20 people looked at the [...]
Lenvatinib plus everolimus for non clear cell kidney cancer
Treating non-clear cell renal cell carcinoma (RCC) is challenging because [...]
One Cancer Voice manifesto
We need to make sure people with cancer aren't just [...]
Differences in survival with tremelimumab due to different types of kidney cancer
Most people have a type of kidney cancer called clear [...]
Checkpoint inhibitor re-challenge after immune-related adverse events
Immunotherapy has revolutionised treatment in many cancers, including renal cell [...]
Surgical delay and survival in patients with T2 kidney tumours
This was a retrospective analysis of 11,848 patients who had [...]
